Phase 4 Osteoporosis Trial, Recruiting (NCT06864130)

Phase 4 Osteoporosis Trial, Recruiting NCT06864130 Sponsor: Odense University Hospital Condition: Osteoporosis

Printed from Voxsanity (voxsanity.com.au) — NCT06864130 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Osteoporosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be female
You must be postmenopausal
You must currently be taking a bone medication called Alendronate
You have been taking Alendronate for more than 3 years AND have not had any bone fractures, OR you have been taking Alendronate for more than 5 years AND your most recent low-impact fracture (a break caused by a minor fall or everyday activity) happened more than 3 years ago

Who may not be able to join:

Your bone density scan shows a very low score (T-score below -3.5) in your hip or lower spine (confirm with trial site)
You are currently taking, or have taken in the last 12 months, steroid medicines taken by mouth or injection (such as prednisone or cortisone)
You have an inflammatory disease that is not well controlled
You currently have an active cancer
Your kidneys are not working well enough (a kidney function test result below a certain level — confirm with trial site)
You have ever had an unusual type of thigh bone fracture called an atypical femur fracture
You currently have a condition called osteonecrosis of the jaw (a serious jaw bone problem)
You are unable to give your consent to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Pernille Hermann, MD, PhD., Odense Universitetshospital / Odense University Hospital

Phone: +4523602366

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06864130

Sponsor: Odense University Hospital

Phase: Phase 4

Status: Recruiting

Condition: Osteoporosis

Trial contact: +4523602366

More information: https://clinicaltrials.gov/study/NCT06864130

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be female
You must be postmenopausal
You must currently be taking a bone medication called Alendronate
You have been taking Alendronate for more than 3 years AND have not had any bone fractures, OR you have been taking Alendronate for more than 5 years AND your most recent low-impact fracture (a break caused by a minor fall or everyday activity) happened more than 3 years ago

Who may not be able to join:

Your bone density scan shows a very low score (T-score below -3.5) in your hip or lower spine (confirm with trial site)
You are currently taking, or have taken in the last 12 months, steroid medicines taken by mouth or injection (such as prednisone or cortisone)
You have an inflammatory disease that is not well controlled
You currently have an active cancer
Your kidneys are not working well enough (a kidney function test result below a certain level — confirm with trial site)
You have ever had an unusual type of thigh bone fracture called an atypical femur fracture
You currently have a condition called osteonecrosis of the jaw (a serious jaw bone problem)
You are unable to give your consent to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

Odense University Hospital

Registry

ClinicalTrials.gov

Start date

21 February 2025

Est. completion

1 March 2029

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Fragility fractures

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov